Daclizumab and Insulin Detemir (Vials)
Determining the interaction of Daclizumab and Insulin Detemir (Vials) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: n.a.
Generic Name: insulin detemir
Brand name: Levemir, Levemir FlexPen, Levemir PenFill, Levemir InnoLet, Levemir FlexTouch
Synonyms: Insulin detemir, Insulin Detemir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab-Insulin detemir Subcutaneous
- Daclizumab-Insulin glargine
- Daclizumab-Insulin Glargine (U-100) Cartridge Systems and Pens
- Daclizumab-Insulin Glargine (U-100) Vials
- Daclizumab-Insulin Glargine (U-300) Pens
- Daclizumab-Insulin glargine and lixisenatide
- Insulin Detemir (Vials)-Daclizumab Subcutaneous
- Insulin Detemir (Vials)-Dacogen
- Insulin Detemir (Vials)-Dacomitinib
- Insulin Detemir (Vials)-Dactinomycin
- Insulin Detemir (Vials)-Dactinomycin Injection
- Insulin Detemir (Vials)-Dactinomycin Intravenous